| Company Name: | Sybron Dental Specialties Inc. | | Ticker Symbol: | SYD | | | WWW Address: | www.sybrondental.com | | CEO: | Floyd W. Pickrell, Jr. | | No. of Employees: | 4,117 | | Common Issue Type: | CS | | Business Description: | A global manufacturer and marketer of a broad range of consumable dental products and related small equipment, as well as a manufacturer and distributor of products for use in infection prevention in both the medical and dental markets.
|
| | | Industry Information: | HEALTH SERVICES - Medical Instruments & Supplies [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | |  | - | - | 0 | 47.08 | 46.99 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,905.6 | 40.6 | 0.80 | 1.85 | 0.00 | 26.0 | 0.0 | 48.00 - 34.17 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 46.99 | $ | | PE Ratio - LTM | 26.0 | |
| Market Capitalisation | 1,905.6 | mil |
| Latest Shares Outstanding | 40.6 | mil |
| Earnings pS (EPS) | 1.85 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 157,801 | $ |
| Effective Tax Rate | 27.0 | % |
| Float | 40.2 | mil |
| Float as % of Shares Outstanding | 99.0 | % |
| Foreign Sales | 274 | mil |
| Domestic Sales | 376 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 37.10 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 59.0 | % |
| EBITDA Margin | 21.9 | % |
| Pre-Tax Profit Margin | 15.4 | % |
| Assets Turnover | 0.9 | % |
| Return on Assets (ROA) | 9.6 | % |
| Return on Equity (ROE) | 16.9 | % |
| Return on Capital Invested (ROCI) | 11.6 | % |
| Current Ratio | 3.4 | |
| Leverage Ratio (Assets/Equity) | 1.8 | |
| Interest Cover | 7.2 | |
| Total Debt/Equity (Gearing Ratio) | 0.46 | |
| LT Debt/Total Capital | 31.0 | % |
| Working Capital pS | 5.48 | $ |
| Cash pS | 1.87 | $ |
| Book-Value pS | 11.00 | $ |
| Tangible Book-Value pS | 2.28 | $ |
| Cash Flow pS | 2.51 | $ |
| Free Cash Flow pS | 1.49 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.27 | |
| Price/Tangible Book Ratio | 20.61 | |
| Price/Cash Flow | 18.7 | |
| Price/Free Cash Flow | 31.5 | |
| P/E as % of Industry Group | 98.0 | % |
| P/E as % of Sector Segment | 55.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 0.1 | 102 | 7,602 | 24,515 |
| 4 Weeks | 48.00 | 46.50 | 47.50 | -1.1 | 102 | 9,554 | 191,076 |
| 13 Weeks | 48.00 | 36.37 | 39.12 | 20.1 | 122 | 7,894 | 497,312 |
| 26 Weeks | 48.00 | 36.37 | 44.26 | 6.2 | 105 | 5,312 | 658,723 |
| 52 Weeks | 48.00 | 34.17 | 38.45 | 22.2 | 115 | 3,617 | 907,847 |
| YTD | 48.00 | 36.37 | - | 18.0 | 116 | 5,987 | 574,784 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 46.99 | 47.01 | 44.01 | 42.39 | 41.69 | 0.80 | -0.04 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 9.52 | 97.2 | 9.34 |
| Income | 15.45 | 82.6 | 14.44 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 4.80 | NA | 45.94 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 12.40 | NA | 15.66 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 8.5 | 10.7 | 13.2 |
| Earnings % | -3.7 | -3.9 | 23.5 |
| EPS % | -6.0 | -6.4 | 20.1 |
| EPS $ | -0.05 | -0.03 | 0.31 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 25.51 |
| Current Ratio | 3.1 |
| Quick Ratio (Acid Test) | 1.8 |
| Liquidity Ratio (Cash) | 0.63 |
| Receivables Turnover | 6.0 |
| Average Collection Period | 60 |
| Working Capital/Equity | 47.6 |
| Working Capital pS | 4.74 |
| Cash-Flow pS | 2.38 |
| Free Cash-Flow pS | 0.27 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 5.18 |
| Financial Leverage Ratio (Assets/Equity) | 1.9 |
| Debt Ratio | 46.4 |
| Total Debt/Equity (Gearing Ratio) | 0.53 |
| LT Debt/Equity | 0.52 |
| LT Debt/Capital Invested | 41.7 |
| LT Debt/Total Liabilities | 60.6 |
| Interest Cover | 6.7 |
| Interest/Capital Invested | 2.81 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 45.47 |
| Tobin's Q Ratio | 2.54 |
| Current P/E Ratio - LTM | 26.00 |
| Enterprise Value (EV)/EBITDA | 15.30 |
| Enterprise Value (EV)/Free Cash Flow | 226.09 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 20.61 |
| Price/Book Ratio - LTM | 4.27 |
| Price/Cash Flow Ratio | 18.7 |
| Price/Free Cash Flow Ratio - LTM | 31.5 |
| Price/Sales Ratio | 2.82 |
| P/E Ratio (1 month ago) - LTM | 26.3 |
| P/E Ratio (26 weeks ago) - LTM | 23.9 |
| P/E Ratio (52 weeks ago) - LTM | 23.4 |
| 5-Y High P/E Ratio | 25.1 |
| 5-Y Low P/E Ratio | 7.8 |
| 5-Y Average P/E Ratio | 18.4 |
| Current P/E Ratio as % of 5-Y Average P/E | 141 |
| P/E as % of Industry Group | 98.0 |
| P/E as % of Sector Segment | 55.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 25.7 |
| PER SHARE FIGURES |
| LT Debt pS | 5.23 |
| Current Liabilities pS | 2.29 |
| Tangible Book Value pS - LTM | 2.28 |
| Book Value pS - LTM | 11.00 |
| Capital Invested pS | 15.12 |
| Cash pS - LTM | 1.87 |
| Cash Flow pS - LTM | 2.51 |
| Free Cash Flow pS - LTM | 1.49 |
| Earnings pS (EPS) | 1.85 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | 1.70 |
| Free Cash Flow Margin 5YEAR AVG | 2.64 |
| Net Profit Margin | 11.8 |
| Net Profit Margin - 5YEAR AVRG. | 10.2 |
| Equity Productivity | 1.62 |
| Return on Equity (ROE) | 19.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 23.8 |
| Capital Invested Productivity | 1.06 |
| Return on Capital Invested (ROCI) | 12.5 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 10.8 |
| Assets Productivity | 0.90 |
| Return on Assets (ROA) | 10.2 |
| Return on Assets (ROA) - 5YEAR AVRG. | 8.7 |
| Gross Profit Margin | 59.0 |
| Gross Profit Margin - 5YEAR AVRG. | 58.3 |
| EBITDA Margin - LTM | 21.9 |
| EBIT Margin - LTM | 17.9 |
| Pre-Tax Profit Margin | 16.2 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 15.6 |
| Effective Tax Rate | 27.0 |
| Effective Tax Rate - 5YEAR AVRG. | 35.1 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 187 |
| Revenue per Employee | 157,801 |
| Net Income per Employee | 18,626 |
| Average Collection Period | 62 |
| Receivables Turnover | 6.0 |
| Day's Inventory Turnover Ratio | 125 |
| Inventory Turnover | 2.9 |
| Inventory/Sales | 14.3 |
| Accounts Payble/Sales | 3.10 |
| Assets/Revenue | 1.11 |
| Net Working Capital Turnover | 3.39 |
| Fixed Assets Turnover | 1.39 |
| Total Assets Turnover | 0.9 |
| Revenue per $ Cash | 11.09 |
| Revenue per $ Plant | 7.40 |
| Revenue per $ Common Equity | 1.62 |
| Revenue per $ Capital Invested | 1.06 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 36.5 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 34.3 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |